#USA #New York #Class Action #Gross Law Firm #Unicycive Therapeutics

Background

Investors of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) who experienced financial losses are being called to action. The Gross Law Firm has announced a class action lawsuit aimed at recovering losses suffered by shareholders during a specific period.

Details of the Class Action

The class period for this action spans from March 29, 2024, to June 27, 2025. During this time, it is alleged that the company issued false and misleading statements concerning its readiness to meet FDA manufacturing compliance requirements. Additionally, claims have been made that the regulatory prospects of the oxylanthanum carbonate new drug application were overstated. Such misrepresentations have left investors exposed to artificial inflation of the company's stock price, leading to significant losses.

Anyone who purchased shares during this timeframe is encouraged to consider joining the lawsuit, as participation does not mandate an appointment as a lead plaintiff.

Important Dates

Potential participants should note the critical registration deadline of October 14, 2025. Interested shareholders can register through the Gross Law Firm's dedicated submission form.

Why You Should Register

By registering, shareholders will be enrolled in a portfolio monitoring system. This service offers updates on the case’s progression, ensuring that investors remain informed about developments. Moreover, there are no costs associated with joining this class action, and it represents a vital opportunity for investors seeking restitution for their losses.

The Role of The Gross Law Firm

The Gross Law Firm is recognized nationally for its commitment to protecting shareholders' rights within the realm of class action lawsuits. They aim to hold companies accountable for misleading or fraudulent statements that have financial impacts. By seeking recovery on behalf of those who have been adversely affected, they contribute to greater corporate accountability.

Next Steps for Interested Shareholders

• - Visit the Gross Law Firm's website to access the registration form for the class action lawsuit.
• - Ensure you register before the deadline, to secure your potential involvement in the recovery process.
• - Keep informed through the updates provided via the monitoring software once registered.

This is a significant opportunity for those who believe they have been wronged by Unicycive Therapeutics to seek justice. There are no financial obligations unless you choose to pursue further legal action.

Conclusion

The Gross Law Firm is dedicated to supporting shareholders who find themselves victims of corporate misconduct. If you or someone you know has suffered losses due to the alleged actions of Unicycive Therapeutics, it may be prudent to reach out for more information and explore your options for participating in this class action lawsuit.